Effect of SR 140333, a selective NK1 antagonist, on antigen-induced oedema formation in rat skin

Journal of Lipid Mediators and Cell Signalling

Volumn 13, Issue 3, 1996, Pages 223-232

  Herbert, Jean Marc ^a   Bernat, André ^a  

^a SANOFI   (France)

Author keywords

Antigen; Edema; Neurokinin 1; Skin; SR 140333; Substance P

Indexed keywords

ALLERGEN; CIMETIDINE; MEPYRAMINE; N(G) NITROARGININE METHYL ESTER; NEUROKININ; NEUROKININ 1 RECEPTOR ANTAGONIST; NOLPITANTIUM; OSANETANT; OVALBUMIN; SAREDUTANT; SUBSTANCE P;

ANAPHYLAXIS; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; INTRADERMAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN EDEMA;

EID: 0029935983     PISSN: 09297855     EISSN: None     Source Type: Journal    
DOI: 10.1016/0929-7855(95)00052-6     Document Type: Article

References (23)

1. Arthus, M. (1903) Injections répétées de sérum de cheval chez le lapin. C.R. Soc. Biol. (Paris) 55, 817-821.
2. Casals-Stenzel, J. (1987) Effect of WEB 2086, a novel antagonist of platelet activating factor in anaphylactic shock in mice. Immunopharmacology 13, 117-124.
3. Cochrane, C.G. (1963) Studies on the localization of circulating antigen-antibody complexes and other macromolecules in vessels. I. Structural studies. J. Exp. Med. 118, 489-494.
4. Cochrane, C.G. and Janoff, A. (1974) The Arthus reaction: a model of neutrophil and complement-mediated injury. In Zweifach, B.W., Grant, L. and McCluskey, R.T. (Eds), The Inflammatory Process, Academic Press, New York, Vol. III, pp. 85-102.
5. Chang, M.M. and Leeman, S.E. (1970) Isolation of a sialogogic peptide from bovine hypothalamic tissue and its characterization as substance P. J. Biol. Chem. 245, 4784-4790.
6. Emonds-Alt, X., Vilain, P., Van Broeck, D., Advenier, C., Naline, E., Neliat, G., Le Fur, G. and Brelière, J.C. (1992) A potent and selective non-peptide antagonist of the neurokinin A (NK2) receptor. Life Sci. 50, 101-106.
7. Emonds-Alt, X., Doutrememuich, J.D., Heaulme, M., Santicci, V., Steinberg, R., Vilain, P., Ducoux, J.P., Proietto, V., Van Broeck, D., Soubrié, P., Le Fur, G. and Brelière, J.C. (1993) In vitro and in vivo biological activities of SR 140333, a novel potent non-peptide tachychinin NK1 receptor antagonist. Eur J. Pharm., 250, 403-413.
8. Emonds-Alt, X., Le Fur, G. and Brelière, J.C. (1994) Non-peptide antagonist of the NK3 tachychinin receptors: discovery and pharmacological characterization. Can. J. Physiol. Pharmacol. 72 (Suppl 2), III.0.9, 3.36-3.37.
9. Erjavec, F., Lembeck, F., Florjanc-Irman, T., Skotitsch, G., Donnerer, J., Sana, A. and Holtzer, R. (1981) Release of histanine by substance P. Arch. Pharmacol. 317, 67-70.
10. Guard, S. and Watson, S.P. (1991) Tachynin receptor types: classification and membrane signalling mechanisms. Neurochem. Int. 18, 149-165.
11. Hellewell, P.G. and Williams, T.J. (1986) A specific antagonist of platelet activating factor suppresses oedema formation in an Arthus reaction but not oedema induced by leukocyte chemoattractants in rabbit skin. J. Immunol. 137, 302-309.
12. Herbert, J.M., Bernat, A., Valette, G., Gigo, V., Lalé, A., Laplace, M.C., Lespy, L., Savi, P., Maffrand, J.P. and Le Fur, G. (1991) Biochemical and pharmacological activities of SR 27417, a highly potent, long acting platelet activating factor receptor antagonist. J. Pharmacol. Exp. Ther. 259, 44-51.
13. Herbert, J.M., Laplace, M.C., Bernat, A., Salel, V. and Maffrand, J.P. (1992) Effect of SR 27417 on oedema formation induced in rabbit skin by platelet activating factor or antigen. Eur. J. Pharmacol. 216, 175-181.
14. Kimura, S., Okada, M., Sugita, Y., Kanasawa, I. and Munekata, E. (1983) Novel neuropeptides, neurokinine alpha, beta, isolated from porcine spinal cord. Proc. Jap. Acad. Sci. Ser. B 59, 101-104.
15. Lembeck, F. and Holzer, P. (1979) Substance P as neurogenic mediator of antidronic vasodilation and neurogenic plasma extravasation. Arch. Pharmacol. 310, 175-183.
16. McLean, S., Ganong, A.H., Seeger, T.F., Bryce, D.K., Pratt, K.G., Reynolds, L.S., Siok, C.J., Lowe, J.A., III and Heym, J. (1991) Activity and distribution of binding sites in brain of a nonpeptide substance P (NK1) receptor antagonist. Science 25, 437-439.
17. Öhlén, A., Thureson, A., Lindbom, L., Persson, MG. and Hedqvist, P. (1989) Substance P activates leukocytes and platelets in rabbit microvessels. Blood Vessels 26, 84-94.
18. Payan, D.G., McGillis, J.P. and Goetzl, E.J. (1986) Neuroimmunology. Adv. Immunol. 39, 299-323.
19. Pernow, B. (1983) Substance P. Pharmacol. Rev. 35, 86-141.
20. Pernow, B. (1985) Role of tachykinins in neurogenic inflammation. J. Immunol. 135, 812-815.
21. Regoli, D. and Nantel, F. (1991) Pharmacology of neurokinin receptors. Biopolymers 31, 777-783.
22. Von Euler, U.S. and Gaddum, J.H. (1931) An unidentified depressor substance in certain tissue extracts, J. Physiol. 72, 74-87.
23. Watling, K.J. and Guard, S. (1992) Tachykinin receptor agonists and antagonists. Neurotransmissions 3, 1-8.